January 2025 – content
Life Sciences
AMSBIO brings Europe Biosite’s acquisitions to six
Microbiologics buys first foreign company
Limerston-backed Cormica makes US purchase
CLS makes first acquisition since joining Limerston investment portfolio
Broken String enters R&D partnership
Research data orchestration specialist Seqera makes first acquisition
Technia acquires US consultancy rights for BIOVIA offering
CrestOptics signs deal with Leica Microsystems
General Laboratory
Coatings equipment and digitisation expertise targets of Judges latest acquisition
Tescan and Shimadzu in co-marketing agreement
Advanced Materials segment to be spun-off by Honeywell
FIB sample preparation expert joins Tescan
IMI pressure control business IMF bought by management with investment help
LabVantage makes two acquisitions over last 24 months
Nanalysis’ service business starts on five-year maintenance contract
Process & hand-held instrumentation
Brooks Instrument buys manufacturer of purity components
Ion Science owner celebrates 25th anniversary at the helm
AI-based bioprocess QC company secures funding
Indicor makes acquisitions in production QA, data loggers and leak detection
Senseca acquires two further companies
Zeteo Tech in R&D collaboration
Financials
Robust underlying growth during ONT’s first half
Merger boosts Standard Biotools’ sales but deepens losses
Protein Sciences at Bio-Techne down in fiscal year
Covid hangover and pharma recession hits LGC
Biopharma spending and acquisition drive Mesa Labs' growth
Smart metering drives growth at Xylem’s MCS division
All DKSH divisions report sales declines as Asia tanks
Labtech halves growth rate
Organic decrease at Judges Scientific during first half
Service revenues overtake product sales at Nanalysis
LSFC businesses still impacts IMI’s LT division
Chinese decline holds back Shimadzu’s Analytical instrument division
Kewaunee’s profitability increases markedly
Renishaw’s analytical sales see lower growth
Advanced Materials business drives Honeywell’s ESS division
Industrial Measurement back to growth at Vaisala
APAC is Alpha MOS’ largest market
Nynomic sees first half decline after false dawn prediction
Kromek reaches adjusted EBITDA profitability
Acquisition contributes most of Ion Science’s calendar 2023 growth
Appointments
